Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Lung Cancer (Amsterdam, Netherlands)|June 24, 2008
Erythema elevatum diutinum as a paraneoplastic syndrome in a patient with pulmonary lymphoepithelioma-like carcinomaTa-Chiang Liu, I-Shu Chen, Tzu-Kai Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2004
Ablating CAR and integrin binding in adenovirus vectors reduces nontarget organ transduction and permits sustained bloodstream persistence following intraperitoneal administrationMasaki Akiyama, Stephen Thorne, David Kirn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenovirusesYaohe Wang, Stephen Thorne, Joseph Hannock, et al.
Nature Biotechnology|October 14, 2003
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor modelsYaohe Wang, Gunnel Hallden, Richard Hill, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2003
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacyGunnel Halldén, Richard Hill, Yaohe Wang, et al.
Translational Vision Science & Technology|August 25, 2020
Quantification of RPE Changes in Choroideremia Using a Photoshop-Based MethodYi Zhai, Manlong Xu, Ioannis S Dimopoulos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
A Phase I Trial of Ad.hIFN-β Gene Therapy for GliomaE Antonio Chiocca, Katie M Smith, Byron McKinney, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
A phase I trial of Ad.hIFN-beta gene therapy for gliomaE Antonio Chiocca, Katie M Smith, Byron McKinney, et al.
Cancer Research|November 5, 2002
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpointsTony Reid, Eva Galanis, James Abbruzzese, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2006
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancerEric J Small, Michael A Carducci, James M Burke, et al.
Pageof 3